Pfizer Study Finds Big Rise in Immunity From COVID Booster
FRIDAY, Nov. 4, 2022 (HealthDay News) — Getting an updated booster for COVID-19 is likely to boost protection substantially, according to a new study released by drug company Pfizer on Friday.The news affirms a decision by the U.S. Food and Drug Admi…
Learn MoreAlcohol-Linked Deaths Soared During Pandemic, CDC Says
FRIDAY, Nov. 4, 2022 (HealthDay News) — Deaths caused by alcohol skyrocketed in the United States between 2019 and 2020 as the COVID-19 pandemic took hold, according to a just-published government report. The alcohol-induced death rate jumped 26% dur…
Learn MoreAlmost 20 Million Older Americans Live With Sight-Robbing Macular Degeneration
FRIDAY, Nov. 4, 2022 (HealthDay News) — In a finding that suggests more Americans than ever are struggling with their sight as they get older, researchers report that nearly 20 million adults have age-related macular degeneration (AMD).Broken down, a…
Learn MoreNew Type of Antibiotic Could Fight Tough-to-Treat UTIs
FRIDAY, Nov. 4, 2022 (HealthDay News) — The world desperately needs new antibiotics to fight infection as bacteria become resistant to existing options.GSK has developed a new antibiotic to treat urinary tract infections (UTIs) that appears to be so …
Learn MoreAHA News: As Cardiac Arrest Deaths Fall, Black and Rural Communities Lag
FRIDAY, Nov. 4, 2022 (American Heart Association News) — Cardiac arrest deaths have dropped significantly in the U.S., except in Black and rural communities, according to new research.Cardiac arrest is when the heart stops beating unexpectedly. A hea…
Learn MoreAHA News: How a Middle-of-the-Night Heart Attack at 40 Became Her Wake-Up Call
FRIDAY, Nov. 4, 2022 (American Heart Association News) — Intense chest pain awakened Natalie Latham from a deep sleep. Surely, she figured, it was from the spicy soup she’d eaten the night before.Natalie had worked a full day in her role as marketing…
Learn MoreAHA: Those With, at Risk for CVD Less Likely to Use Wearables
FRIDAY, Nov. 4, 2022 (HealthDay News) — Individuals with, or at risk for, cardiovascular disease (CVD), are less likely to use wearable devices that monitor and track health or physical activity, according to a study presented at the American Heart A…
Learn MoreAHA: Heart Disease Death Rates in U.S. Spiked in 2020
FRIDAY, Nov. 4, 2022 (HealthDay News) — Deaths from heart disease increased in 2020 in the United States, following a steady decline from 2010 to 2019, according to a study presented at the American Heart Association Scientific Sessions 2022, held fr…
Learn MoreAHA: Once-Daily Edoxaban Seems Safe for Pediatric Cardiac Patients
FRIDAY, Nov. 4, 2022 (HealthDay News) — Once-daily edoxaban seems safe and effective for pediatric patients with cardiac disease, according to a study presented at the American Heart Association Scientific Sessions 2022, held from Nov. 5 to 7 in Chic…
Learn MoreDapagliflozin May Be Cost-Effective for Treating CKD
FRIDAY, Nov. 4, 2022 (HealthDay News) — Dapagliflozin seems to be cost-effective in the United Kingdom, Germany, and Spain for patients meeting the eligibility criteria for the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Diseas…
Learn More